11 – 20 of 45
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
(
- Contribution to journal › Article
-
Mark
Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12p12.3
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer
(
- Contribution to journal › Article
-
Mark
WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolism.
(
- Contribution to journal › Article
-
Mark
Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids
(
- Contribution to journal › Article
- 2013
-
Mark
Hemochromatosis (HFE) gene mutations and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
(
- Contribution to journal › Article
- 2012
-
Mark
Genetic variation in alcohol dehydrogenase (ADH1A, ADH1B, ADH1C, ADH7) and aldehyde dehydrogenase (ALDH2), alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
(
- Contribution to journal › Article
-
Mark
Med1 plays a critical role in the development of tamoxifen resistance
(
- Contribution to journal › Article
- 2011
-
Mark
Interaction between functional polymorphic variants in cytokine genes, established risk factors and susceptibility to basal cell carcinoma of skin
(
- Contribution to journal › Article
-
Mark
CHRNA5 as negative regulator of nicotine signaling in normal and cancer bronchial cells : effects on motility, migration and p63 expression
(
- Contribution to journal › Article